RobertJ.BattatMD

PubMed

• Higher Adalimumab Trough Levels Are Associated with Histologic Remission and Mucosal Healing in Inflammatory Bowel Disease.
  Rochelle Wong, Lihui Qin, Yushan Pan, Prerna Mahtani, Randy Longman, Dana Lukin, Ellen Scherl, Robert Battat> ;Journal of Clinical Medicine. 2023 Oct 27
• The Relationship Between the Endoscopic Healing Index, Fecal Calprotectin, and Magnetic Resonance Enterography in Crohn's Disease.
  Emily S Smith, Johnson Chen, Yushan Pan, Prerna Mahtani, Dana Lukin, Waseem Ahmed, Randy Longman, Robert Burakoff, Ellen Scherl, Robert Battat> ;Journal of Clinical Gastroenterology. 2023 Aug 21
• 1 citations
  Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease.
  Kaylie Chen, Johnson Chen, Emily Smith, Prerna Mathani, Randy Longman, Dana Lukin, Ellen Scherl, Juliette Gerber, Robert Battat> ;Inflammatory Bowel Diseases. 2023 Sep 1
• Predicting inpatient mortality in patients with inflammatory bowel disease: A machine learning approach.
  Paris Charilaou, Sonmoon Mohapatra, Sotirios Doukas, Maanit Kohli, Dhruvil Radadiya, Kalpit Devani, Arkady Broder, Olivier Elemento, Dana J Lukin, Robert Battat> ;Journal of Gastroenterology and Hepatology. 2023 Feb 1
• 11 citations
  Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease.
  Benjamin Langan Gordon, Jonathan S Galati, Stevie Yang, Randy S Longman, Dana Lukin, Ellen J Scherl, Robert Battat> ;World Journal of Gastroenterology. 2022 Sep 7
• 3 citations
  Serum Monitoring of Recurrence in Post-Operative Crohn's Disease: Have We Arrived?
  Robert Battat> ;Journal of Crohn's & Colitis. 2022 Dec 5
• 15 citations
  Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS-CoV-2 Vaccination.
  Paris Charilaou, Christopher Tricarico, Robert Battat, Ellen J Scherl, Randy S Longman, Dana J Lukin> ;Clinical Gastroenterology and Hepatology. 2022 Jun 1
• Authors' Reply to "Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammat...
  Robert Battat> ;Inflammatory Bowel Diseases. 2022 May 4
• 22 citations
  Machine learning models and over-fitting considerations.
  Paris Charilaou, Robert Battat> ;World Journal of Gastroenterology. 2022 Feb 7
• Fucosyltransferase 2 Mutations Are Associated With a Favorable Clinical Course in Crohn's Disease.
  Robert Battat, Abdulrahman Qatomah, Uri Kopylov, Jonathan Wyse, Albert Cohen, Waqqas Afif, Peter L. Lakatos, Ernest G. Seidman, Alain Bitton, Talat Bessissow> ;Journal of Clinical Gastroenterology. 2021 Nov 4
• 15 citations
  Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis.
  Fatema Alrashed, Robert Battat, Israa Abdullah, Aline Charabaty, Mohammad Shehab> ;BMJ Open Gastroenterology. 2021 Oct 1
• Is Proactive Therapeutic Drug Monitoring Ready for the Spotlight in Inflammatory Bowel Disease? Follow the Data.
  Robert Battat, Millie D. Long> ;The American Journal of Gastroenterology. 2021 Sep 13
• 3 citations
  Systematic review and Meta-analysis: Clinical, Endoscopic, Histologic and Safety Placebo Rates in Induction and Maintenance trials of Ulcerative Colitis.
  Rocio Sedano, Malcolm Hogan, Tran M Nguyen, Joshua Chang, Guangyong Zou, John K MacDonald, Niels Vande Casteele, Jurij Hanzel, Eileen Crowley, Robert Battat, Parambir ...> ;Journal of Crohn's & Colitis. 2021 Jul 26
• Therapeutic Drug Monitoring of Certolizumab Pegol: Can Real-World Data Translate to Clinical Practice?
  Robert Battat> ;Crohn's & Colitis 360. 2021 Jul 1
• 2 citations
  Serum Ustekinumab Concentrations Are Associated With Remission in Crohn's Disease Defined by a Serum-Based Endoscopic Healing Index.
  Margaret Walshe, Krzysztof Borowski, Robert Battat, David Hudesman, Douglas C Wolf, Lauren Okada, Anjali Jain, Mark S Silverberg> ;Crohn's & Colitis 360. 2021 Jul 1
• 10 citations
  No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD.
  Dana J. Lukin, Gabriela Funez-dePagnier, Svetlana Lima, Daniel Lai, Lucia Duenas-Bianchi, Waseem Ahmed, Vinita Jacob, Robert Battat, Ellen Scherl, Randy S. Longman> ;Clinical Gastroenterology and Hepatology. 2021 Jun 5
• 15 citations
  Advances in the Comprehensive Management of Postoperative Crohn’s Disease
  Robert Battat, William J. Sandborn> ;Clinical Gastroenterology and Hepatology. 2021 Apr 2
• 62 citations
  Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
  Waseem Ahmed, Jonathan S. Galati, Anand Kumar, Paul J. Christos, Randy S. Longman, Dana J. Lukin, Ellen Scherl, Robert Battat> ;Clinical Gastroenterology and Hepatology. 2021 Mar 31
• 47 citations
  An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials
  Christopher Ma, Rocio Sedano, Ahmed Almradi, Niels Vande Casteele, Claire E Parker, Leonardo Guizzetti, David F. Schaeffer, Robert H. Riddell, Reetesh K. Pai, Robert B...> ;Gastroenterology. 2021 Jun 1
• 5 citations
  Relationship Between Patient Sex and Serum Tumor Necrosis Factor Antagonist Drug and Anti-drug Antibody Concentrations in Inflammatory Bowel Disease; A Nationwide Coho...
  Mohammad Shehab, Hajer Alasfour, Israa Abdullah, Ghadeer Alhendi, Anwar Alhadab, Ahmad Alfadhli, Ali H Ziyab, Robert Battat> ;Frontiers in Medicine. 2021 Jan 1
• 14 citations
  Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease.
  Robert Battat, Dana J. Lukin, Ellen Scherl, Suresh Pola, Anand Kumar, Lauren Okada, Lei Yang, Anjali Jain, Corey A. Siegel> ;Inflammatory Bowel Diseases. 2021 Aug 19
• 6 citations
  Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's disease.
  Ariela K. Holmer, Robert Battat, Parambir S. Dulai, Niels Vande Casteele, Nghia Nguyen, Anjali Jain, Ara Miralles, Jennifer Neill, Helen Le, Siddharth Singh, Jesus Riv...> ;Therapeutic Advances in Gastroenterology. 2020 Nov 12
• 6 citations
  Evaluating the optimum number of biopsies to assess histological inflammation in ulcerative colitis: a retrospective cohort study
  Robert Battat, Niels Vande Casteele, Rish K. Pai, Zhongya Wang, Guangyong Zou, John W.D. McDonald, Marjolijn Duijvestein, Jenny Jeyarajah, Claire E Parker, Tanja van V...> ;Alimentary Pharmacology & Therapeutics. 2020 Nov 1
• 1 citations
  Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel Diseases
  Andres Yarur, Parakkal Deepak, Niels Vande Casteele, Robert Battat, Anjali Jain, Lauren Okada, Mark T. Osterman, Miguel Regueiro> ;Digestive Diseases and Sciences. 2021 Oct 1
• Patient-Preferences Favoring Treatment Discontinuation Are Reduced With Vedolizumab and Ustekinumab Compared With TNF Antagonists in Inflammatory Bowel Disease.
  Anand Kumar, Emilie S Kim, Philip Kozan, Randy S Longman, Ellen J Scherl, Robert J Battat, Dana J Lukin, Jacob, V.> ;Crohn's & Colitis 360. 2020 Oct 1
• Join now to see all